PAX4 and Hyperglycemia: DOX-mediated induction of Pax4 prevented hyperglycaemia development in BPTL animals up to 4 weeks after immunisation, whereas Pax4R129W induction partially reduced the hyperglycaemic incidence in mutBPTL mice.